The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

NMOR     4-nitrosomorpholine

Synonyms: NSC-139, CCRIS 473, NSC139, CHEMBL165908, LS-254, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Nitrosomorpholine


Psychiatry related information on Nitrosomorpholine


High impact information on Nitrosomorpholine


Chemical compound and disease context of Nitrosomorpholine


Biological context of Nitrosomorpholine


Anatomical context of Nitrosomorpholine


Associations of Nitrosomorpholine with other chemical compounds


Gene context of Nitrosomorpholine


Analytical, diagnostic and therapeutic context of Nitrosomorpholine


  1. N-Nitrosodiethanolamine in synthetic cutting fluids: a part-per-hundred impurity. Fan, T.Y., Morrison, J., Rounbehler, D.P., Ross, R., Fine, D.H., Miles, W., Sen, N.P. Science (1977) [Pubmed]
  2. Tumor induction by carcinogenic agents in aquarium fish. Pliss, G.B., Khudoley, V.V. J. Natl. Cancer Inst. (1975) [Pubmed]
  3. Persistently increased expression of a 3-methylcholanthrene-inducible phenol uridine diphosphate-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas. Bock, K.W., Münzel, P.A., Röhrdanz, E., Schrenk, D., Eriksson, L.C. Cancer Res. (1990) [Pubmed]
  4. Dose-response study with N-nitrosomorpholine in drinking water of F-344 rats. Lijinsky, W., Kovatch, R.M., Riggs, C.W., Walters, P.T. Cancer Res. (1988) [Pubmed]
  5. Effect of ethanol on early stages in nitrosamine carcinogenesis in rat liver. Schwarz, M., Buchmann, A., Wiesbeck, G., Kunz, W. Cancer Lett. (1983) [Pubmed]
  6. In vivo formation of N-nitrosomorpholine in CD-1 mice exposed by inhalation to nitrogen dioxide and by gavage to morpholine. Van Stee, E.W., Sloane, R.A., Simmons, J.E., Brunnemann, K.D. J. Natl. Cancer Inst. (1983) [Pubmed]
  7. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella. Raineri, R., Poiley, J.A., Andrews, A.W., Pienta, R.J., Lijinsky, W. J. Natl. Cancer Inst. (1981) [Pubmed]
  8. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Iyengar, R., Stuehr, D.J., Marletta, M.A. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  9. Cocarcinogenic effects of islet hormones and N-nitrosomorpholine in hepatocarcinogenesis after intrahepatic transplantation of pancreatic islets in streptozotocin-diabetic rats. Dombrowski, F., Jost, C.M., Manekeller, S., Evert, M. Cancer Res. (2005) [Pubmed]
  10. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Schulte-Hermann, R., Timmermann-Trosiener, I., Barthel, G., Bursch, W. Cancer Res. (1990) [Pubmed]
  11. Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants. Zeindl-Eberhart, E., Klugbauer, S., Dimitrijevic, N., Jungblut, P.R., Lamer, S., Rabes, H.M. Electrophoresis (2001) [Pubmed]
  12. Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone. Weber, E., Moore, M.A., Bannasch, P. Carcinogenesis (1988) [Pubmed]
  13. Endogenous incorporation of nitric oxide from L-arginine into N-nitrosomorpholine stimulated by Escherichia coli lipopolysaccharide in the rat. Leaf, C.D., Wishnok, J.S., Tannenbaum, S.R. Carcinogenesis (1991) [Pubmed]
  14. Bacterial formation of N-nitroso compounds from administered precursors in the rat stomach after omeprazole-induced achlorhydria. Calmels, S., Béréziat, J.C., Ohshima, H., Bartsch, H. Carcinogenesis (1991) [Pubmed]
  15. Urinary markers for exposures to alkylating or nitrosating agents. Wishnok, J.S., Tannenbaum, S.R., Stillwell, W.G., Glogowski, J.A., Leaf, C.D. Environ. Health Perspect. (1993) [Pubmed]
  16. Separation in distinct subpopulations by elutriation of liver cells following exposure of rats to N-nitrosomorpholine. Wanson, J.C., Bernaert, D., Penasse, W., Mosselmans, R., Bannasch, P. Cancer Res. (1980) [Pubmed]
  17. Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro. Lewis, R.S., Tamir, S., Tannenbaum, S.R., Deen, W.M. J. Biol. Chem. (1995) [Pubmed]
  18. Transfer of bcl-xs plasmid is effective in preventing and inhibiting rat hepatocellular carcinoma induced by N-nitrosomorpholine. Baba, M., Iishi, H., Tatsuta, M. Gene Ther. (2001) [Pubmed]
  19. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine. Weber, E., Bannasch, P. Carcinogenesis (1994) [Pubmed]
  20. Accumulation of p53 protein in chemically induced oval cells during early stages of rodent hepatocarcinogenesis. Wirnitzer, U., Enzmann, H., Rosenbruch, M., Bomhard, E.M. Carcinogenesis (1995) [Pubmed]
  21. Absence of volatile nitrosamines in human feces. Lee, L., Archer, M.C., Bruce, W.R. Cancer Res. (1981) [Pubmed]
  22. Sequential morphologic alterations in the bronchial epithelium of Syrian golden hamsters during N-nitrosomorpholine-induced pulmonary tumorigenesis. Reznik-Schüller, H. Am. J. Pathol. (1977) [Pubmed]
  23. Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Grasl-Kraupp, B., Luebeck, G., Wagner, A., Löw-Baselli, A., de Gunst, M., Waldhör, T., Moolgavkar, S., Schulte-Hermann, R. Carcinogenesis (2000) [Pubmed]
  24. Endogenous formation of N-nitrosomorpholine in mice from 15NO2 by inhalation and morpholine by gavage. Van Stee, E.W., Sloane, R.A., Simmons, J.E., Moorman, M.P., Brunnemann, K.D. Carcinogenesis (1995) [Pubmed]
  25. A sensitive method for detecting in vivo formation of N-nitrosomorpholine and its application to rats given low doses of morpholine and sodium nitrite. Hecht, S.S., Morrison, J.B. Cancer Res. (1984) [Pubmed]
  26. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W., Schulte-Hermann, R. Hepatology (1995) [Pubmed]
  27. Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors. Cortinovis, C., Klimek, F., Nogueira, E. Am. J. Pathol. (1991) [Pubmed]
  28. Differential expression of key enzymes of energy metabolism in preneoplastic and neoplastic rat liver lesions induced by N-nitrosomorpholine and dehydroepiandrosterone. Mayer, D., Metzger, C., Leonetti, P., Beier, K., Benner, A., Bannasch, P. Int. J. Cancer (1998) [Pubmed]
  29. Enhancement by isoproterenol of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats. Uehara, H., Nakaizumi, A., Baba, M., Iishi, H., Tatsuta, M. Int. J. Cancer (1993) [Pubmed]
  30. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. Fujita, K., Kamataki, T. Environ. Mol. Mutagen. (2001) [Pubmed]
  31. Role of transforming growth factor alpha and prostaglandins in preferential growth of preneoplastic rat hepatocytes. Hufnagl, K., Parzefall, W., Marian, B., Käfer, M., Bukowska, K., Schulte-Hermann, R., Grasl-Kraupp, B. Carcinogenesis (2001) [Pubmed]
  32. Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes. Masui, T., Nakanishi, H., Inada, K., Imai, T., Mizoguchi, Y., Yada, H., Futakuchi, M., Shirai, T., Tatematsu, M. Cancer Lett. (1997) [Pubmed]
  33. Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis. Nehrbass, D., Klimek, F., Bannasch, P. Am. J. Pathol. (1998) [Pubmed]
  34. Inhibition by somatostatin of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats. Nakaizumi, A., Uehara, H., Baba, M., Iishi, H., Tatsuta, M. Carcinogenesis (1993) [Pubmed]
  35. Cleavage of poly(ADP-ribose) transferase during p53-independent apoptosis in rat liver after treatment with N-nitrosomorpholine and cyproterone acetate. Weşierska-Gadek, J., Bugajska-Schretter, A., Löw-Baselli, A., Grasl-Kraupp, B. Mol. Carcinog. (1999) [Pubmed]
  36. Establishment of an in vivo highly metastatic rat hepatocellular carcinoma model. Futakuchi, M., Hirose, M., Ogiso, T., Kato, K., Sano, M., Ogawa, K., Shirai, T. Jpn. J. Cancer Res. (1999) [Pubmed]
WikiGenes - Universities